Select survey responses.
Question (max score = 6) Median (IQR)
The printed material I received was helpful to me 6 (5,6) I have kept the printed material for later use 6 (5,6) I prefer to receive health information on a device than on paper Intrauterine growth restriction (IUGR) is commonly caused by placental insufficiency, resulting in an inadequate supply of oxygen and nutrients to the fetus. The fetal brain is particularly vulnerable to IUGR conditions and abnormal neurodevelopment is common in the IUGR infant. Recent evidence suggests inflammation may be a key mechanism responsible for the progression of brain impairment in the IUGR newborn. We hypothesised placental stem cell treatment will reduce inflammation and neuronal and white matter impairment in the IUGR newborn piglet brain.
Methods: We used the preclinical piglet model of growth restriction where IUGR occurs spontaneously. Newborn IUGR (<5th centile) and normally grown control piglets were collected on day of birth (P1) and received either i.v. vehicle (saline) or stem cells (1 million MSCs and 1 million ECFCs). Animals were monitored and cared for until euthanasia on postnatal day 4 (P4). Neuronal and white matter impairment and markers of inflammation were investigated using IHC and qPCR.
Results: Markers of inflammation were increased at P4 in the IUGR brain with concurrent decreases in myelination and neuronal cell counts. No adverse immune response (temperature, weight) was evident following stem cell treatment.
Conclusions: Hindering the actions of neuroinflammatory mediators following birth may be a key mechanism to reduce adverse brain outcomes in the IUGR newborn. 
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